EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Therapeutic applications of ginseng for skeletal muscle-related disorder management

Syed Sayeed Ahmad, Hee Jin Chun, Khurshid Ahmad, Inho Choi

Journal of Ginseng Research · 2024-01 · 48 (1) · 12-19

DOI: 10.1016/j.jgr.2023.06.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Ginseng Research, 2024-01. Verfasst von Syed Sayeed Ahmad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skeletal muscle (SM) is the largest organ of the body and is largely responsible for the metabolism required to maintain body functions. Furthermore, the maintenance of SM is dependent on the activation of muscle satellite (stem) cells (MSCs) and the subsequent proliferation and fusion of differentiating myoblasts into mature myofibers (myogenesis). Natural compounds are being used as therapeutic options to promote SM regeneration during aging, muscle atrophy, sarcopenia, cachexia, or obesity. In particular, ginseng-derived compounds have been utilized in these contexts, though ginsenoside Rg1 is mostly used for SM mass management. These compounds primarily function by activating the Akt/mTOR signaling pathway, upregulating myogenin and MyoD to induce muscle hypertrophy, downregulating atrophic factors (atrogin1, muscle ring-finger protein-1, myostatin, and mitochondrial reactive oxygen species production), and suppressing the expressions of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in cachexia. Ginsenoside compounds are also used for obesity management, and their anti-obesity effects are attributed to peroxisome proliferator activated receptor gamma (PPARγ) inhibition, AMPK activation, glucose transporter type 4 (GLUT4) translocation, and increased phosphorylations of insulin resistance (IR), insulin receptor substrate-1 (IRS-1), and Akt. This review was undertaken to provide an overview of the use of ginseng-related compounds for the management of SM-related disorders.

Schlagwörter

Stichwörter der Autor:innen

CachexiaGinsengMuscle atrophySarcopenia

Autor:innen und Institutionen

  • Department of Medical Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea.
  • Research Institute of Cell Culture, Yeungnam University, Gyeongsan, Republic of Korea.

Förderung

  • Ministry of Education
  • National Research Foundation of Korea

Zitieren

APA

Ahmad, S. S., Chun, H. J., Ahmad, K., & Choi, I. (2024). Therapeutic applications of ginseng for skeletal muscle-related disorder management. Journal of Ginseng Research, 48(1), 12-19. https://doi.org/10.1016/j.jgr.2023.06.003

Vancouver

Ahmad SS, Chun HJ, Ahmad K, Choi I. Therapeutic applications of ginseng for skeletal muscle-related disorder management. Journal of Ginseng Research. 2024;48(1):12-19. doi:10.1016/j.jgr.2023.06.003

BibTeX
@article{Ahmad2024,
  author = {Ahmad, Syed Sayeed and Chun, Hee Jin and Ahmad, Khurshid and Choi, Inho},
  title = {Therapeutic applications of ginseng for skeletal muscle-related disorder management},
  journal = {Journal of Ginseng Research},
  year = {2024},
  volume = {48},
  number = {1},
  pages = {12--19},
  doi = {10.1016/j.jgr.2023.06.003}
}
Kostenlos starten →